These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3002784)

  • 21. Bicistronic lentiviral vector corrects beta-hexosaminidase deficiency in transduced and cross-corrected human Sandhoff fibroblasts.
    Arfi A; Bourgoin C; Basso L; Emiliani C; Tancini B; Chigorno V; Li YT; Orlacchio A; Poenaru L; Sonnino S; Caillaud C
    Neurobiol Dis; 2005 Nov; 20(2):583-93. PubMed ID: 15953731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Usefulness of 4-methylumbelliferyl-6-sulfo-2-acetamido-2-deoxy-beta-D-glucopyrano sid e for the diagnosis of GM2 gangliosidoses in leukocytes.
    Inui K; Wenger DA
    Clin Genet; 1984 Oct; 26(4):318-21. PubMed ID: 6238730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GM2-gangliosidosis, Type 2 (Sandhoff disease).
    Varadkar AM; Mahale SD; Suchak RH; Patel ZM; Dhareshwar SS; Ambani LM
    Indian Pediatr; 1983 Apr; 20(4):302-5. PubMed ID: 6225733
    [No Abstract]   [Full Text] [Related]  

  • 24. Thermodynamic determination of plasma and leukocyte beta-hexosaminidase isoenzymes in homozygote and heterozygote carriers for the GM2 gangliosidosis B1 variant.
    Casal JA; Pérez LF; Tutor JC
    Am J Clin Pathol; 2003 May; 119(5):684-8. PubMed ID: 12760286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enzyme immunoassay of beta-hexosaminidase A and B in serum: carrier detection of GM2-gangliosidoses, and equivalence of enzyme activity and enzyme protein reactivity.
    Isaksson A; Hultberg B; Masson P; Landels E; Fensom A
    Clin Chem; 1993 Jul; 39(7):1412-5. PubMed ID: 8330398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In situ assessment of beta-hexosaminidase activity.
    Lacorazza HD; Jendoubi M
    Biotechniques; 1995 Sep; 19(3):434-40. PubMed ID: 7495557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physiological substrates for human lysosomal beta -hexosaminidase S.
    Hepbildikler ST; Sandhoff R; Kolzer M; Proia RL; Sandhoff K
    J Biol Chem; 2002 Jan; 277(4):2562-72. PubMed ID: 11707436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Juvenile Sandhoff disease: some properties of the residual hexosaminidase in cultured fibroblasts.
    Wood S; MacDougall BG
    Am J Hum Genet; 1976 Sep; 28(5):489-95. PubMed ID: 10724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preferential beta-hexosaminidase (Hex) A (alpha beta) formation in the absence of beta-Hex B (beta beta) due to heterozygous point mutations present in beta-Hex beta-chain alleles of a motor neuron disease patient.
    Banerjee P; Boyers MJ; Berry-Kravis E; Dawson G
    J Biol Chem; 1994 Feb; 269(7):4819-26. PubMed ID: 8106452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antigenic homology of feline and human beta-hexosaminidase.
    O'Neil DC; Bartholomew WR; Rattazzi MC
    Biochim Biophys Acta; 1979 Sep; 580(1):1-9. PubMed ID: 94833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in serum N-acetyl-beta-hexosaminidase levels after treatment of hypothyroid and hyperthyroid individuals with L-thyroxine and propylthiouracil.
    Oberkotter LV; Tenore A; Koldovsky O
    Clin Chim Acta; 1980 Nov; 108(1):61-6. PubMed ID: 6450007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GM2 gangliosidoses: a review of cases confirmed by beta-N-acetylhexosaminidase assay.
    Christopher R; Rangaswamy GR; Shetty KT
    Indian J Pediatr; 1995; 62(4):479-83. PubMed ID: 10829909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Compound heterozygosity with two novel mutations in the HEXB gene produces adult Sandhoff disease presenting as a motor neuron disease phenotype.
    Yoshizawa T; Kohno Y; Nissato S; Shoji S
    J Neurol Sci; 2002 Mar; 195(2):129-38. PubMed ID: 11897243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High- and low-uptake forms of beta-hexosaminidase in human platelets. Selective retention of the high-uptake form during stimulation with thrombin.
    Vladutiu GD; Dangelmaier CA; Amigone V; Van Oost BA; Holmsen H
    Biochim Biophys Acta; 1984 Dec; 802(3):435-41. PubMed ID: 6239657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new form of residual hexosaminidase activity in infantile Tay Sachs disease fibroblasts.
    Hechtman P; Khoo K; Isaacs C
    Clin Genet; 1983 Sep; 24(3):206-15. PubMed ID: 6226462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thermodynamic characterisation of the mutated isoenzyme A of beta-N-acetylhexosaminidase in GM2-gangliosidosis B1 variant.
    Pérez LF; Ribeiro HM; Casal JA; Pinto RA; Sá Miranda MC; Tutor JC
    Clin Chim Acta; 1999 Jul; 285(1-2):45-51. PubMed ID: 10481922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The specificity of human N-acetyl-beta-D-hexosaminidases towards glycosphincolipids is determined by an activator protein.
    Conzelmann E; Sandhoff K
    Adv Exp Med Biol; 1980; 125():295-306. PubMed ID: 6444774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Widespread distribution of beta-hexosaminidase activity in the brain of a Sandhoff mouse model after coinjection of adenoviral vector and mannitol.
    Bourgoin C; Emiliani C; Kremer EJ; Gelot A; Tancini B; Gravel RA; Drugan C; Orlacchio A; Poenaru L; Caillaud C
    Gene Ther; 2003 Oct; 10(21):1841-9. PubMed ID: 12960974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Purification and some properties of liver and brain beta-N-acetyl-hexosaminidase S.
    Potier M; Teitelbaum J; Melancon SB; Dallaire L
    Biochim Biophys Acta; 1979 Jan; 566(1):80-7. PubMed ID: 758959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic correction in microglia derived from Sandhoff disease model mice.
    Tsuji D; Kuroki A; Ishibashi Y; Itakura T; Itoh K
    J Neurochem; 2005 Sep; 94(6):1631-8. PubMed ID: 16092933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.